Why Do Phase III Clinical Trials in Oncology Fail so Often?

被引：40
作者：
Amiri-Kordestani, Laleh [1 ]
Fojo, Tito [1 ]
机构：
[1] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 08期
关键词：
DRUG DEVELOPMENT; TARGETED AGENTS; STABLE DISEASE; END-POINT; CHEMOTHERAPY; SURVIVAL; CANCER; BENEFIT; DESIGNS;
D O I：
10.1093/jnci/djs180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：568 / 569
页数：2
相关论文
共 50 条
[41]   Phase 0 clinical trials in oncology: a paradigm shift for early drug development? [J].
Chris H. Takimoto .
Cancer Chemotherapy and Pharmacology, 2009, 63 :703-709
[42]   Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials [J].
Rami, Avina ;
DuBois, Steven G. ;
Campbell, Kevin .
CLINICAL TRIALS, 2024, 21 (02) :211-219
[43]   Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review [J].
Rivoirard, Romain ;
Langrand-Escure, Julien ;
Oriol, Mathieu ;
Tinquaut, Fabien ;
Chauvin, Franck ;
Rancoule, Chloe ;
Magne, Nicolas ;
Bourmaud, Aurelie .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 :78-83
[44]   Utilization of palliative care consultations in pediatric oncology phase I clinical trials [J].
Cuviello, Andrea ;
Boss, Renee ;
Shah, Nirali ;
Battles, Haven ;
Beri, Andrea ;
Wiener, Lori .
PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
[45]   Phase 3 Oncology Clinical Trials in South Africa: Experimentation or Therapeutic Misconception? [J].
Malan, Tina ;
Moodley, Keymanthri .
JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2016, 11 (01) :47-56
[46]   Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience [J].
Manresa, Anna Pujol ;
Lopez, Susana Buendia ;
Andion, Maitane ;
Herrero, Blanca ;
Lassaletta, Alvaro ;
Ramirez, Manuel ;
Ruano, David ;
Hernandez-Marques, Carmen ;
Varo, Amalia ;
de Rojas, Teresa ;
Hernandez, Marta Cortes ;
Verdu-Amoros, Jaime ;
Prado, Silvia Martin ;
Artigas, Andrea ;
Redondo, Esther ;
Pato, Julia Ruiz ;
Lopez, Pilar Herreros ;
Sevilla, Julian ;
Madero, Luis ;
Moreno, Lucas ;
Sirvent, Francisco Bautista ;
Rubio-San-Simon, Alba .
FRONTIERS IN PEDIATRICS, 2024, 12
[47]   Months and Severity Score (MOSES) in a Phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials [J].
Ranjan, Nilesh ;
Chopra, Supriya ;
Mangaj, Akshay ;
Rane, Pallavi ;
Charnalia, Mayuri ;
Kannan, Sadhana ;
Dora, Tapas ;
Engineer, Reena ;
Mahantshetty, Umesh ;
Gurram, Lavanya ;
Mittal, Prachi ;
Ghosh, Jaya ;
Maheshwari, Amita ;
Shylasree, T. S. ;
Gupta, Sudeep ;
Shrivastava, S. K. .
ECLINICALMEDICINE, 2022, 47
[48]   Clinical Reasons for Initiation of Adjuvant Phase III Trials on Colon Cancer [J].
de Gramont, Aimery ;
Chibaudel, Benoist ;
Bonnetain, Franck ;
Dumont, Sarah ;
Larsen, Annette K. ;
Andre, Thierry .
CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) :292-301
[49]   Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials [J].
Gan, Chun L. ;
Stukalin, Igor ;
Meyers, Daniel E. ;
Dudani, Shaan ;
Grosjean, Heidi A., I ;
Dolter, Samantha ;
Ewanchuk, Benjamin W. ;
Goutam, Siddhartha ;
Sander, Michael ;
Wells, Connor ;
Pabani, Aliyah ;
Cheng, Tina ;
Monzon, Jose ;
Morris, Don ;
Basappa, Naveen S. ;
Pal, Sumanta K. ;
Wood, Lori A. ;
Donskov, Frede ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. .
EUROPEAN JOURNAL OF CANCER, 2021, 151 :115-125
[50]   Phase 0 Clinical Trials in Oncology: An Exploratory Methodology for Constructing a Study With Patients Undergoing Surgery for Metastatic Disease [J].
Pocard, Marc ;
Soria, Jean-Charles ;
Aldaz-Carroll, Lydia ;
Bellet, Dominique .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4551-4553
12345